Ectopic expression of PAX5 promotes self renewal of bi-phenotypic myeloid progenitors co-expressing myeloid and B-cell lineage associated genes.
(2007) In Blood 109(Jan 11). p.3697-3705- Abstract
- The transcription factor PAX5 is a critical regulator of B-cell commitment and development. Although normally not expressed in myeloid progenitors, PAX5 has recently been shown to be frequently expressed in myeloid malignancies and to suppress expression of myeloid differentiation genes, compatible with an effect on the differentiation or maintenance of myeloid progenitors. However, previous studies in which PAX5 was ectopically expressed in normal myeloid progenitors in vivo and in vitro provided conflicting results as to the effect of PAX5 on myeloid development. Herein, we demonstrate that on ectopic expression of PAX5 in bone marrow multipotent stem/progenitor cells, cells with a biphenotypic B220+GR-1/MAC-1+ phenotype are produced.... (More)
- The transcription factor PAX5 is a critical regulator of B-cell commitment and development. Although normally not expressed in myeloid progenitors, PAX5 has recently been shown to be frequently expressed in myeloid malignancies and to suppress expression of myeloid differentiation genes, compatible with an effect on the differentiation or maintenance of myeloid progenitors. However, previous studies in which PAX5 was ectopically expressed in normal myeloid progenitors in vivo and in vitro provided conflicting results as to the effect of PAX5 on myeloid development. Herein, we demonstrate that on ectopic expression of PAX5 in bone marrow multipotent stem/progenitor cells, cells with a biphenotypic B220+GR-1/MAC-1+ phenotype are produced. These remain cytokine-dependent, but unlike control-transduced cells they sustain long-term generation of myeloid progenitors in vitro and remain capable of myeloid differentiation. Notably, PAX5+B220+GR-1/MAC-1+ myeloid progenitors coexpress, at the single-cell level, myeloid genes and otherwise B-cell–specific PAX5 target genes. These findings establish that ectopic expression of PAX5 introduces extensive self-renewal properties in otherwise short-lived myeloid progenitors. Along with the established ectopic expression of PAX5 in acute myeloid leukemia, this motivates a careful investigation of the potential involvement of ectopic PAX5 expression in myeloid and biphenotypic leukemias. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/164975
- author
- Anderson, Kristina LU ; Rusterholz, Corinne LU ; Månsson, Robert LU ; Jensen, Christina LU ; Bacos, Karl LU ; Zandi, Sasan LU ; Sasaki, Yutaka LU ; Nerlov, Claus LU ; Sigvardsson, Mikael LU and Jacobsen, Sten Eirik W LU
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Blood
- volume
- 109
- issue
- Jan 11
- pages
- 3697 - 3705
- publisher
- American Society of Hematology
- external identifiers
-
- wos:000246091400022
- scopus:34247223642
- pmid:17218387
- ISSN
- 1528-0020
- DOI
- 10.1182/blood-2006-05-026021
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Stem Cell Center (013041110), Division of Molecular Medicine and Gene Therapy (013022010), Molecular Metabolism (013212001)
- id
- 302ad945-41aa-43db-927b-dc9dc5a6f9c9 (old id 164975)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17218387&dopt=Abstract
- date added to LUP
- 2016-04-01 11:49:17
- date last changed
- 2022-02-03 05:35:13
@article{302ad945-41aa-43db-927b-dc9dc5a6f9c9, abstract = {{The transcription factor PAX5 is a critical regulator of B-cell commitment and development. Although normally not expressed in myeloid progenitors, PAX5 has recently been shown to be frequently expressed in myeloid malignancies and to suppress expression of myeloid differentiation genes, compatible with an effect on the differentiation or maintenance of myeloid progenitors. However, previous studies in which PAX5 was ectopically expressed in normal myeloid progenitors in vivo and in vitro provided conflicting results as to the effect of PAX5 on myeloid development. Herein, we demonstrate that on ectopic expression of PAX5 in bone marrow multipotent stem/progenitor cells, cells with a biphenotypic B220+GR-1/MAC-1+ phenotype are produced. These remain cytokine-dependent, but unlike control-transduced cells they sustain long-term generation of myeloid progenitors in vitro and remain capable of myeloid differentiation. Notably, PAX5+B220+GR-1/MAC-1+ myeloid progenitors coexpress, at the single-cell level, myeloid genes and otherwise B-cell–specific PAX5 target genes. These findings establish that ectopic expression of PAX5 introduces extensive self-renewal properties in otherwise short-lived myeloid progenitors. Along with the established ectopic expression of PAX5 in acute myeloid leukemia, this motivates a careful investigation of the potential involvement of ectopic PAX5 expression in myeloid and biphenotypic leukemias.}}, author = {{Anderson, Kristina and Rusterholz, Corinne and Månsson, Robert and Jensen, Christina and Bacos, Karl and Zandi, Sasan and Sasaki, Yutaka and Nerlov, Claus and Sigvardsson, Mikael and Jacobsen, Sten Eirik W}}, issn = {{1528-0020}}, language = {{eng}}, number = {{Jan 11}}, pages = {{3697--3705}}, publisher = {{American Society of Hematology}}, series = {{Blood}}, title = {{Ectopic expression of PAX5 promotes self renewal of bi-phenotypic myeloid progenitors co-expressing myeloid and B-cell lineage associated genes.}}, url = {{http://dx.doi.org/10.1182/blood-2006-05-026021}}, doi = {{10.1182/blood-2006-05-026021}}, volume = {{109}}, year = {{2007}}, }